No abstract available
Plain language summary
This study assesses mean emissions and costs and estimated total yearly emissions and costs for US-branded inhalers prescribed to Medicare Part D and Medicaid beneficiaries.
MeSH terms
-
Aerosol Propellants* / chemistry
-
Aerosol Propellants* / economics
-
Asthma / drug therapy
-
Asthma / economics
-
Bronchodilator Agents / administration & dosage
-
Bronchodilator Agents / chemistry
-
Bronchodilator Agents / economics
-
Drug Costs / statistics & numerical data
-
Drug Prescriptions / economics
-
Drug Prescriptions / statistics & numerical data
-
Fluorocarbons / chemistry
-
Fluorocarbons / economics
-
Greenhouse Effect* / economics
-
Greenhouse Effect* / prevention & control
-
Greenhouse Gases* / chemistry
-
Greenhouse Gases* / economics
-
Humans
-
Medicaid / economics
-
Medicaid / statistics & numerical data
-
Medicare Part D / economics
-
Medicare Part D / statistics & numerical data
-
Nebulizers and Vaporizers* / economics
-
Nebulizers and Vaporizers* / statistics & numerical data
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Pulmonary Disease, Chronic Obstructive / economics
-
United States
Substances
-
Greenhouse Gases
-
Aerosol Propellants
-
Fluorocarbons
-
Bronchodilator Agents